
Ifytrox TBS 250mg/31.25mg Injection
Marketer
Syntonic Lifesciences
Salt Composition
Ceftriaxone (250mg) + Tazobactum (31.25mg)
Overview Ifytrox TBS 250mg/31.25mg Injection
Combiflox, a 250mg/31.25mg injectable antibiotic, combats diverse bacterial infections by inhibiting microbial proliferation. Administration requires strict medical oversight; complete the prescribed course regardless of symptom improvement to ensure efficacy. Premature cessation may compromise treatment. Minor side effects, including nausea, vomiting, diarrhea, and dyspepsia, may occur. Severe reactions necessitate immediate medical attention. Report any allergies (rash, itching, swelling, dyspnea) immediately. Disclose all current medications, including those for pre-existing conditions, to your physician before use. Consult your doctor before using this medicine if pregnant or breastfeeding. Alcohol consumption should be avoided due to potential increased drowsiness. While generally non-impairing, avoid driving if drowsiness or dizziness occurs. Adequate rest, nutrition, and hydration are crucial for optimal recovery. Monitoring via laboratory tests may be conducted to assess treatment response.
Primary Ingredients of Ifytrox TBS 250mg/31.25mg Injection
No text provided to rephrase.
Uses of Ifytrox TBS 250mg/31.25mg Injection
Infections caused by bacteria
Major Benefits of Ifytrox TBS 250mg/31.25mg Injection:
This medication will be administered by your healthcare provider. Self-medication is strongly discouraged.
Common Side effects of Ifytrox TBS 250mg/31.25mg Injection:
- Diarrhea
- Increased liver enzymes
- Allergic reaction
- Rash
How to use Ifytrox TBS 250mg/31.25mg Injection:
The medication will be administered by your healthcare provider. Self-medication is strongly discouraged.
How Ifytrox TBS 250mg/31.25mg Injection works:
The injectable formulation Ifytrox TBS 250mg/31.25mg unites Ceftriaxone, a broad-spectrum antibiotic, with Tazobactum, a beta-lactamase inhibitor. Ceftriaxone's mechanism involves disrupting bacterial cell wall synthesis, thereby hindering bacterial growth. Tazobactum counteracts bacterial resistance mechanisms, augmenting Ceftriaxone's antibacterial efficacy.
SAFETY ADVICE
AlcoholSAFE
Ingestion of alcohol alongside Ifytrox TBS 250mg/31.25mg Injection presents no known adverse reactions.
PregnancySAFE IF PRESCRIBED
The injectable medication Ifytrox TBS 250mg/31.25mg is typically deemed safe for use during pregnancy. Preclinical trials in animals revealed minimal or no negative consequences for fetal development; however, clinical data from human trials are scarce.
Breast feedingCAUTION
The administration of Ifytrox TBS 250mg/31.25mg Injection necessitates prudence during lactation. Mothers should discontinue breastfeeding throughout the treatment course and until the medication is fully cleared from their system.
DrivingUNSAFE
The administration of Ifytrox TBS 250mg/31.25mg Injection can induce drowsiness, blurred vision, and dizziness, potentially impairing alertness. Driving should be avoided if such effects manifest.
KidneyCONSULT YOUR DOCTOR
Insufficient data exists regarding the administration of Ifytrox TBS 250mg/31.25mg Injection to individuals with renal impairment. Physician consultation is advised.
LiverCAUTION
Patients with severe hepatic impairment should use Ifytrox TBS 250mg/31.25mg Injection cautiously, potentially requiring dosage modification. Medical advice is recommended. Dosage alteration for Ifytrox TBS 250mg/31.25mg Injection is unnecessary for individuals with mild to moderate liver dysfunction.
What if you forget to take Ifytrox TBS 250mg/31.25mg Injection :
Omit a dose of Ifytrox TBS 250mg/31.25mg Injection? Seek medical advice immediately.
Facts to Know About Ifytrox TBS 250mg/31.25mg Injection
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Anti-Infective Agents |
